G1/G2子宫内膜样子宫内膜癌患者合并附件恶性肿瘤的术前预测模型
基于1996至2017年复旦大学附属肿瘤医院1511例接受手术的G1/G2子宫内膜样子宫内膜癌患者,构建预测合并附件恶性肿瘤的列线图。多因素分析显示CA125升高、深肌层浸润及MRI/手术探查疑似附件受累为独立预测因子(AUC=0.786)。该模型可能帮助临床医生决定是否保留卵巢。
要点
- 1511例G1/G2子宫内膜样子宫内膜癌患者中66例(4.4%)合并附件恶性肿瘤。
- CA125>35 U/ml、深肌层浸润、MRI/手术探查疑似附件受累为独立预测因子,AUC=0.786。
- 在338例有MMR结果的患者中,MSI-high组合并附件恶性肿瘤比例为5.7%(5/87),MSS组为4.4%(11/251)。
核心结论
- 构建了包含术前和术中因素的列线图预测G1/G2子宫内膜样子宫内膜癌患者合并附件恶性肿瘤,可能帮助临床医生决定是否保留卵巢。
研究设计与样本
- 纳入1996至2017年在复旦大学附属肿瘤医院接受手术的G1/G2子宫内膜样子宫内膜癌患者1511例,采用单因素和多因素logistic回归识别预测因子并构建列线图,评估区分度和校准度。
主要发现
- 1511例患者中66例(4.4%)合并附件恶性肿瘤,其中51例转移,15例同时原发。
- 单因素分析中CA125>35 U/ml(P<.001)、组织学分级(P=0.047)、MRI肌层浸润深度(P=0.011)、MRI/手术探查附件受累(P<.001)为显著预测因子。
- 多因素分析显示CA125升高(P<.001;OR=2.945;95%CI 1.700-5.101)、深肌层浸润(P=.011;OR=2.194;95%CI 1.200-4.011)、MRI/手术探查疑似附件受累(P<.001;OR=11.524;95%CI 6.726-19.744)为独立预测因子(AUC=0.786)。
- 在338例有MMR结果的患者中,87例(25.7%)检测为MSI-high;MSI-high组5.7%(5/87)诊断为合并附件恶性肿瘤,MSS组为4.4%(11/251)。
临床怎么用
- 作者认为该列线图可能帮助临床医生对G1/G2子宫内膜样子宫内膜癌患者做出保留卵巢的决策。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify the predictors of coexisting adnexa malignancy (CAM) before surgery for patients with G1/G2 endometrioid endometrial cancer (EEC). METHODS: Patients with G1/G2 EEC who received surgery in Fudan University Shanghai Cancer Center from 1996 to 2017 were enrolled. Univariate and multivariate logistic regression were performed to identify the predictors for CAM, and the nomogram was constructed and evaluated the discrimination and calibration. RESULTS: Among the 1511 patients in the study cohort, 66 (4.4%) coexisted adnexa malignancy (51 metastatic and 15 synchronous primaries). In the univariate logistic regression analysis, CA125 level (>35 U/ml), histologic grades, myometrial invasion depth in magnetic resonance imaging (MRI), adnexal involvement in MRI/surgical exploration (SEP) were found to be significant predictors for CAM (P < .001, 0.047, 0.011, <0.001, respectively). The multivariate analysis demonstrated that high CA125 level (P < .001; OR: 2.945; 95%CI: 1.700-5.101), deep myometrial invasion (P = .011; OR: 2.194; 95%CI: 1.200-4.011), and suspected adnexal involvement in MRI/SEP (P < .001; OR: 11.524; 95%CI: 6.726-19.744) were independent predictors for CAM (AUC = 0.786). In 338 patients with MMR results, eighty-seven (25.7%) were detected MSI-high. There were 5.7% (5/87) patients diagnosed with CAM in the MSI-high group compared with 4.4% (11/251) in the MSS group. CONCLUSIONS: A nomogram with pre- and intra-operative factors was constructed to predict CAM in G1/G2 EEC patients, which may help clinicians in decision-making for ovarian preservation for these patients.
引用
- Shen L, Xie L, Li R, et al. A preoperative prediction model for predicting coexisting adnexa malignancy of patients with G1/G2 endometrioid endometrial cancer. Gynecol Oncol. 2020. PMID: 32847677. doi:10.1016/j.ygyno.2020.08.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。